Cognizant Technology Solutions (CTSH)
(Delayed Data from NSDQ)
$75.86 USD
+0.39 (0.52%)
Updated Aug 16, 2024 04:00 PM ET
After-Market: $75.85 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth C Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$75.86 USD
+0.39 (0.52%)
Updated Aug 16, 2024 04:00 PM ET
After-Market: $75.85 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth C Momentum D VGM
Zacks News
Headquartered in Teaneck, NJ, Cognizant Technology Solutions Corporation is a leading professional services company. The company was spun off from Dun & Bradstreet in 1996 and went public in 1998. Cognizant’s services include digital services and solutions, consulting, application development, systems integration, application testing, application maintenance, infrastructure services, and business process services. Cognizant reported revenues of $16.78 billion in 2019. Revenues from clients added during 2019, including those related to acquisitions were $234 million.
Cognizant (CTSH) Q1 Earnings & Revenues Beat Estimates
by Zacks Equity Research
Cognizant (CTSH) reported non GAAP earnings of $1.06 per share, which beat the Zacks Consensus Estimate by a penny.
What's in the Offing for Cognizant (CTSH) in Q1 Earnings?
by Zacks Equity Research
Cognizant's (CTSH) first-quarter results are likely to benefit from domain expertise and partnerships with leading IT-firms.
Q2 Holdings (QTWO) Hits Fresh Highs: Is There Still Room to Run?
by Zacks Equity Research
Q2 Holdings, Inc. is at a 52-week high, but can investors hope for more gains in the future? We take a look at the fundamentals for QTWO for clues.
Has Cognizant Technology (CTSH) Outpaced Other Computer and Technology Stocks This Year?
by Zacks Equity Research
Is Cognizant Technology Solutions Corporation (CTSH) Outperforming Other Computer and Technology Stocks This Year?
Accenture Rides on Cloud Strength & Buyouts, Competition Rife
by Zacks Equity Research
Accenture's (ACN) strategy of enhancing its cloud capabilities through acquisitions and partnerships is encouraging.
Add These 7 GARP Stocks to Your Portfolio for Maximum Returns
by Zacks Equity Research
If you're looking for a profitable portfolio of stocks that will offer the best of value and growth investing, try the growth at a reasonable price or GARP strategy.
Why You Must Retain Guidewire (GWRE) Stock in Your Portfolio
by Zacks Equity Research
We suggest investors to hold Guidewire (GWRE) stock in their portfolio. The stock is riding significantly on meaningful transition to cloud-based model, customer wins and positive acquisition synergies.
Accenture (ACN) Earnings and Revenues Beat Estimates in Q2
by Zacks Equity Research
Accenture (ACN) delivered impressive results for the second-quarter of fiscal 2018 on the back of robust performance of the product portfolio.
Red Hat (RHT) Q4 Earnings to Gain From Portfolio Strength
by Zacks Equity Research
Red Hat's (RHT) fourth-quarter fiscal 2018 earnings are likely to benefit from strong demand for hybrid cloud technology solutions as well as aggressive cross-selling.
Zacks.com featured highlights include: Platform Specialty, Xylem, Cognizant Technology, Huntington Ingalls and Applied Materials
by Zacks Equity Research
Zacks.com featured highlights include: Platform Specialty, Xylem, Cognizant Technology, Huntington Ingalls and Applied Materials
5 Stocks With Robust Sales Growth to Add to Your Portfolio
by Zacks Equity Research
Sustainable improvement in the bottom line comes on the back of solid sales growth.
Why VMware is a Solid Choice for Growth Investors in 2018
by Zacks Equity Research
VMware (VMW) is a solid choice for growth focus investors, considering strong growth projections.
The Zacks Analyst Blog Highlights: Applied Materials, Micron Technology, Seagate Technology, Intel and Cognizant Technology Solutions
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Applied Materials, Micron Technology, Seagate Technology, Intel and Cognizant Technology Solutions
Tech Stocks Stage Stunning Recovery: 5 Nasdaq 100 Picks
by Swarup Gupta
Investors are on the lookout for tech stocks in an environment where growth-oriented investments are a favored option.
7 GARP Stocks to Scoop Up for Maximum Returns
by Zacks Equity Research
Growth at a reasonable price or GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount.
Why Is Cognizant (CTSH) Up 8.8% Since Its Last Earnings Report?
by Zacks Equity Research
Cognizant (CTSH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
6 Large-Cap Technology Stocks for Momentum Investors
by Aniruddha Ganguly
We pick six technology stocks with market capital of more than $15 billion that are ideal for momentum investors.
Guidewire (GWRE) to Commence Public & Senior Notes Offerings
by Zacks Equity Research
Guidewire (GWRE) to raise $575 million in total with its equity and senior note offerings.
6 Top-Ranked Stocks That Can Make You Jeff Bezos Like Rich
by Aniruddha Ganguly
We pick six stocks that have significant growth prospects and can enhance investors' wealth like Amazon CEO Jeff Bezos.
Genpact (G) Earnings and Revenues Beat Estimates in Q4
by Zacks Equity Research
Genpact's (G) AI based platform called Genpact Cora and its recent acquisitions are proving to be beneficial for the top line.
Top Research Reports for Novartis, BP & Biogen
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Novartis (NVS), BP (BP) and Biogen (BIIB).
Cognizant (CTSH) Q4 Earnings Beat Estimates, Revenues Up Y/Y
by Zacks Equity Research
Cognizant's (CTSH) fourth-quarter results benefits from growth across all four segments.
Cognizant (CTSH) Q4 Earnings Top Estimates, Revenues In Line
by Zacks Equity Research
Cognizant (CTSH) reported non GAAP earnings of $1.03 per share, which beat the Zacks Consensus Estimate by six cents.
Cognizant (CTSH) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Cognizant's (CTSH) fourth-quarter results are likely to benefit from domain expertise and partnerships with leading IT-firms.
25 Stocks Powering the $300B SPY ETF for 25 Years
by Sweta Killa
We have highlighted the 25 best-performing stocks in the SPY over the past 25 years.